Join us later this month for conversations with a venture capitalist, a pharmaceutical giant, and a multinational IT corporation. If that’s not compelling enough, what about a neurosurgeon, a scholar, an entrepreneur, an IT guru, or a fellow with $50 million to spend on health-related innovation?

Here’s who’s coming to town to talk with you in the next few weeks.

Teo Forcht Dagi, Partner, HLM Venture Partners – March 21
Daniel Böck, Director Business Development, GlaxoSmithKline Inc. – March 29
John Weigelt, National Technology Officer, Microsoft Canada – March 29

Come, listen, and tell them about you and your venture. RSVP today.

Teo Forcht Dagi, Partner, HLM Venture Partners (WWW.HLMVP.COM) – Teo is a partner at HLM Venture Partners focusing on biomedical technologies and health care. Prior to joining HLM in 2006, he was managing partner of Cordova Ventures in Atlanta and principal at Access Partners in Connecticut. Formerly, he was a practicing neurosurgeon as well as a successful innovator in medical devices and health-care services with regulatory and clinical trials experience and faculty appointments at Harvard-MIT, Brown University and the National Institutes of Health. Teo serves as a board of directors observer at MedVentive and Teladoc. He was previously a director of 14 publicly-traded and privately-held companies, including Atherogenics, Argos Therapeutics, Axela Biosensors, and Inhibitex. He is on the advisory boards of Vengrowth and Oxford Finance Corporation, and sits on the steering committee of the Harvard-MIT program in biomedical entrepreneurship. Teo is also a member of Innovacorp’s Science and Technology Advisory Council.

Early-Stage Biomedical Investment and Innovation: Current Trends
Wednesday, March 21
9:00 am – 10:00 am (refreshments provided)
Innovacorp Enterprise Centre
1344 Summer Street, Halifax

RSVP to April Forrest at AFORREST@INNOVACORP.CA (NB: please indicate the session you’re attending) by Monday, March 19.

Daniel Böck, Director of Business Development, GlaxoSmithKline Inc. (WWW.GSK.CA– Daniel is director of business development for GlaxoSmithKline (GSK) and a main contact for the company’s $50 million Canada Life Sciences Innovation Fund. Announced in November 2011, the fund supports early-stage breakthrough science and accelerates the commercialization of Canadian innovations through investment in the country’s academic and health research institutions, translational research centres, and start-up companies. The fund gives companies, academic and research organizations an opportunity to benefit from GSK’s leading global R&D experience. GSK is a leading research-based pharmaceutical company with a mission to improve the quality of human life by enabling people to do more, feel better and live longer. This mission gives GSK the purpose to develop innovative medicines, vaccines and health-care solutions that help millions of people. The company is consistently recognized as one of the 50 best employers in Canada and is a top 15 investor in Canadian R&D, contributing more than $141 million in 2010 alone.

A Conversation with Daniel Böck from GlaxoSmithKline Inc.
Thursday, March 29
9:00 am – 10:00 am (refreshments provided)
Innovacorp Enterprise Centre
1344 Summer Street, Halifax

RSVP to April Forrest at AFORREST@INNOVACORP.CA (NB: please indicate the session you’re attending) by Tuesday, March 27.

John Weigelt, National Technology Officer, Microsoft Canada (WWW.MICROSOFT.COM– As the national technology officer for Microsoft Canada, John drives the company’s strategic policy and technology efforts. In this role, he is the lead public advocate on issues such as the development of a national technology policy and the use of technology by government, education and the health-care community. John is also responsible for the development and implementation of strategies that strengthen the company’s relationships with the Canadian technology industry at large. Prior to joining Microsoft, John was senior director of architecture, standards and engineering at the Chief Information Officer Branch of the Treasury Board of Canada Secretariat. There, he was responsible for the development of the Government of Canada Enterprise architecture, which provided the foundation for Canada’s Government On‐Line initiative and Treasury Board’s information management and information technology standards, and provided support for the Critical Information Infrastructure Protection Policy. John holds a master’s degree in computer and communications security engineering from the Royal Military College of Canada. He is also a member of Innovacorp’s Science and Technology Advisory Council.

A Conversation with John Weigelt from Microsoft Canada
Thursday, March 29
12:00 pm – 1:00 pm (refreshments provided)
Technology Innovation Centre
1 Research Drive, Dartmouth

RSVP to April Forrest at AFORREST@INNOVACORP.CA (NB: please indicate the session you’re attending) by Tuesday, March 27.